 NovaBay Pharmaceuticals, Inc. NYSE American: NBY announces an agreement with Shenzhen Microprofit Biotech Co., Ltd. to become the exclusive U.S. distributor of a rapid, finger prick test to determine the presence of COVID-19 or a potential indication of antibody immunity to COVID-19. The fluorecare SARS-CoV-2 IgG IgM Antibody Combined colloidal gold chromatographic immunoassay Test Kit is a point-of-care test to be administered by healthcare professionals. The test uses a drop of blood for the detection of COVID-19 antibodies with results available in approximately 10 minutes. 